Tranzyme completes drug discovery partnership with Bristol-Myers

Tranzyme Pharma has completed the chemistry-based drug discovery partnership and transferred the resulting compounds to Bristol-Myers Squibb to advance the development.

---

Tranzyme Pharma Could be in for Big Paydays From Drug Giant Bristol-Myers Squibb Company

RESEARCH TRIANGLE PARK, N.C., Jan. 4, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule macrocycl…

---

Bristol-Myers Squibb Company-Pfizer Inc.’s Blood Thinner Eliquis Wins FDA Approval

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYS: BMY) and Pfizer Inc. (NYS: PFE) announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixab…

---

Bristol-Pfizer’s blood thinner Eliquis wins FDA approval

Bristol-Myers Squibb and Pfizer's Eliquis, or apixaban, has been approved by the FDA to reduce the risk of strokes and blood  -More- …

---